NCAPG and central nervous system cancer: Assessment of the prognostic value of NCAPG expression in glioma patients subgrouped by histological type, sex, IDH mutation status, WHO grade, chromosome 1p/19q co-deletion, and age showed that high expression of NCAPG was associated with poor prognosis in all of these groups (Figures 3A–C).